sublingual cyclobenzaprine

July 7, 2020July 7, 2020

Bedtime Fibromyalgia Therapy TNX-102 SL Sees Faster-than-expected Trial Enrollment

News

Enrollment in the RELIEF Phase 3 trial assessing TNX-102 SL (sublingual cyclobenzaprine) as a nighttime treatment for pain and disturbed sleep due to fibromyalgia has been faster than expected, according ... Read more

November 13, 2019November 13, 2019

TNX-102 SL Holds Potential to Treat FM Symptoms, Phase 3 Trial Data Show

News

The investigational therapy TNX-102 SL (sublingual cyclobenzaprine) had significant beneficial impact on sleep quality and fatigue, although it did not reduce pain levels in patients with fibromyalgia, results from a ... Read more